{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:12:52Z","timestamp":1740107572755,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00595-024-02837-7","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T22:01:54Z","timestamp":1713304914000},"page":"1022-1030","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of sentinel lymph-node biopsy after neoadjuvant chemotherapy in clinically axilla node-negative patients"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0732-9007","authenticated-orcid":false,"given":"Atilla","family":"\u00c7elik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4695-6828","authenticated-orcid":false,"given":"Fikret","family":"\u00c7al\u0131ko\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6333-4919","authenticated-orcid":false,"given":"Ahmet","family":"Akba\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8420-9298","authenticated-orcid":false,"given":"G\u00fcl\u00e7in","family":"Ercan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Muhammedo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,16]]},"reference":[{"issue":"6","key":"2837_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"2837_CR2","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.21037\/tcr.2019.06.19","volume":"8","author":"Y Yang","year":"2019","unstructured":"Yang Y, Liu G, Qin L, Ye L, Zhu F, Ying Y. Overexpression of UHRF1 and its potential role in the development of invasive ductal breast cancer validated by integrative bioinformatics and immunohistochemistry analyses. Transl Cancer Res. 2019;8(4):1086\u201396.","journal-title":"Transl Cancer Res"},{"key":"2837_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fonc.2018.00084","volume":"8","author":"M De Meric de Bellefon","year":"2018","unstructured":"De Meric de Bellefon M, Lemanski C, Ducteil A, Fenoglietto P, Azria D, Bourgier C. Management of the axilla in the era of breast cancer heterogeneity. Front Oncol. 2018;8:84.","journal-title":"Front Oncol"},{"issue":"10","key":"2837_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927\u201333.","journal-title":"Lancet Oncol"},{"issue":"19","key":"2837_CR5","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.3390\/cancers13195031","volume":"13","author":"MCL Peek","year":"2021","unstructured":"Peek MCL, Saeki K, Ohashi K, Chikaki S, Baker R, Nakagawa T, et al. Optimization of SPIO injection for sentinel lymph node dissection in a rat model. Cancers (Basel). 2021;13(19):5031.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"2837_CR6","first-page":"156","volume":"55","author":"B Citgez","year":"2021","unstructured":"Citgez B, Yigit B, Yetkin SG. Management of the axilla and the breast after neoadjuvant chemotherapy in patients with breast cancer: a systematic review. Med Bull SisliEtfal Hospital. 2021;55(2):156.","journal-title":"Med Bull SisliEtfal Hospital"},{"issue":"14","key":"2837_CR7","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, et al. Alliance for Clinical Trials in Oncology. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310(14):1455\u201361.","journal-title":"JAMA"},{"key":"2837_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.breast.2021.07.015","volume":"59","author":"S Cao","year":"2021","unstructured":"Cao S, Liu X, Cui J, Liu X, Zhong J, Yang Z, et al. Feasibility and reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive axillary nodes at initial diagnosis: an up-to-date meta-analysis of 3,578 patients. Breast. 2021;59:256\u201369.","journal-title":"Breast"},{"issue":"1","key":"2837_CR9","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12957-017-1264-7","volume":"15","author":"J Guo","year":"2017","unstructured":"Guo J, Yang H, Wang S, Cao Y, Liu M, Xie F, et al. Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study. World J Surg Oncol. 2017;15(1):196.","journal-title":"World J Surg Oncol"},{"key":"2837_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.amsu.2020.09.030","volume":"59","author":"P Chirappapha","year":"2020","unstructured":"Chirappapha P, Chatmongkonwat T, Lertsithichai P, Pipatsakulroj W, Sritara C, Sukarayothin T. Sentinel lymph node biopsy after neoadjuvant treatment of breast cancer using blue dye, radioisotope, and indocyanine green: prospective cohort study. Ann Med Surg (Lond). 2020;59:156\u201360.","journal-title":"Ann Med Surg (Lond)."},{"issue":"3","key":"2837_CR11","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.breast.2015.02.034","volume":"24","author":"S Tsuyuki","year":"2015","unstructured":"Tsuyuki S, Yamaguchi A, Kawata Y, Kawaguchi K. Assessing the effects of neoadjuvant chemotherapy on lymphatic pathways to sentinel lymph nodes in cases of breast cancer: usefulness of the indocyanine green-fluorescence method. Breast. 2015;24(3):298\u2013301.","journal-title":"Breast"},{"issue":"7","key":"2837_CR12","first-page":"609","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, et al. Sentinel-lymph-nodebiopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentrecohortstudy. LancetOncol. 2013;14(7):609\u201318.","journal-title":"LancetOncol"},{"key":"2837_CR13","unstructured":"Sancar BAYAR, Seher DEM\u0130RER Lokal \u0130leri Meme Kanserinde Cerrahi Tedavi T\u00fcrkiyeCumhuriyetiSa\u011fl\u0131kBakanl\u0131\u011f\u0131Sa\u011fl\u0131kHizmetleriGenelM\u00fcd\u00fcrl\u00fc\u011f\u00fc, Meme KanseriKorunma, Tarama, Tan\u0131, Tedavive\u0130zlemKlinikRehberi (Versiyon 1.0, Ankara, 2020p. 68)"},{"issue":"3","key":"2837_CR14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"JF Boileau","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M, Holloway CM, Gaboury L, Sideris L, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J ClinOncol. 2015;33(3):258\u201364.","journal-title":"J ClinOncol"},{"issue":"3","key":"2837_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/BF02984543","volume":"11","author":"SH Kang","year":"2004","unstructured":"Kang SH, Kang JH, Choi EA, Lee ES. Sentinel lymph node biopsy after neoadjuvant chemotherapy. Breast Cancer. 2004;11(3):233\u201341 (discussion 264-6).","journal-title":"Breast Cancer"},{"issue":"1","key":"2837_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejso.2009.10.015","volume":"36","author":"V Ozmen","year":"2010","unstructured":"Ozmen V, Unal ES, Muslumanoglu ME, Igci A, Canbay E, Ozcinar B, et al. Axillary sentinel node biopsy after neoadjuvant chemotherapy. Eur J SurgOncol. 2010;36(1):23\u20139.","journal-title":"Eur J SurgOncol"},{"issue":"4","key":"2837_CR17","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.ejso.2020.10.014","volume":"47","author":"S Kahler-Ribeiro-Fontana","year":"2021","unstructured":"Kahler-Ribeiro-Fontana S, Pagan E, Magnoni F, Vicini E, Morigi C, Corso G, et al. Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up. Eur J Surg Oncol. 2021;47(4):804\u201312.","journal-title":"Eur J Surg Oncol"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-024-02837-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00595-024-02837-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-024-02837-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T14:33:53Z","timestamp":1724423633000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00595-024-02837-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["2837"],"URL":"https:\/\/doi.org\/10.1007\/s00595-024-02837-7","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"type":"print","value":"0941-1291"},{"type":"electronic","value":"1436-2813"}],"subject":[],"published":{"date-parts":[[2024,4,16]]},"assertion":[{"value":"29 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We have no conflicts of interest to declare in association with this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}